The extent to which neuronal or glial genome instability would drive disease in ALS-FUS relative to other mechanisms, including translational deregulation, splicing deregulation, nuclear import/export deregulation, and proteostasis defects, remains to be determined. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.